{"id": "train_6_12", "text": "This study is the first to confirm the association between @GENE$ and @DISEASE$.", "text_with_entity_marker": "This study is the first to confirm the association between [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "This study is the first to confirm the association between [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [59, 65], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_idx_in_text_with_typed_entity_marker": [65, 71], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_5", "text": "We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and @DISEASE$, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and [E2]@DISEASE$[/E2], overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and [DISEASE]@DISEASE$[/DISEASE], overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_226", "text": "Association of a genetic polymorphism in @GENE$ with @DISEASE$ and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.", "text_with_entity_marker": "Association of a genetic polymorphism in [E1]@GENE$[/E1] with [E2]@DISEASE$[/E2] and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.", "text_with_typed_entity_marker": "Association of a genetic polymorphism in [GENE]@GENE$[/GENE] with [DISEASE]@DISEASE$[/DISEASE] and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [41, 47], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 53], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [53, 62], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_idx_in_text_with_typed_entity_marker": [75, 84], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_66", "text": "The C-allele of PKLR rs3020781 and the T-allele of @GENE$ rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The C-allele of PKLR rs3020781 and the T-allele of [E1]@GENE$[/E1] rs7538490 are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The C-allele of PKLR rs3020781 and the T-allele of [GENE]@GENE$[/GENE] rs7538490 are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [51, 57], "entity_1_idx_in_text_with_entity_marker": [55, 61], "entity_1_idx_in_text_with_typed_entity_marker": [57, 63], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [108, 117], "entity_2_idx_in_text_with_entity_marker": [121, 130], "entity_2_idx_in_text_with_typed_entity_marker": [130, 139], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_222", "text": "Additionally, the @GENE$ and the NOS1AP genotypes were demonstrated not to have a major influence on @DISEASE$.", "text_with_entity_marker": "Additionally, the [E1]@GENE$[/E1] and the NOS1AP genotypes were demonstrated not to have a major influence on [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Additionally, the [GENE]@GENE$[/GENE] and the NOS1AP genotypes were demonstrated not to have a major influence on [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_39", "text": "Allelic and non-allelic heterogeneities in @DISEASE$ revealed by @GENE$ mutational analysis.", "text_with_entity_marker": "Allelic and non-allelic heterogeneities in [E1]@DISEASE$[/E1] revealed by [E2]@GENE$[/E2] mutational analysis.", "text_with_typed_entity_marker": "Allelic and non-allelic heterogeneities in [DISEASE]@DISEASE$[/DISEASE] revealed by [GENE]@GENE$[/GENE] mutational analysis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [43, 52], "entity_1_idx_in_text_with_entity_marker": [47, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 61], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [65, 71], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_idx_in_text_with_typed_entity_marker": [90, 96], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_286", "text": "The haplotypes constructed from the three SNPs (@GENE$, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs ([E1]@GENE$[/E1], rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs ([GENE]@GENE$[/GENE], rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_284", "text": "Our objective was to determine whether variants in the @GENE$ gene are associated with @DISEASE$ in the Japanese population.", "text_with_entity_marker": "Our objective was to determine whether variants in the [E1]@GENE$[/E1] gene are associated with [E2]@DISEASE$[/E2] in the Japanese population.", "text_with_typed_entity_marker": "Our objective was to determine whether variants in the [GENE]@GENE$[/GENE] gene are associated with [DISEASE]@DISEASE$[/DISEASE] in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [55, 61], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_idx_in_text_with_typed_entity_marker": [61, 67], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_75", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and @GENE$ (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [E1]@GENE$[/E1] (TNF)-alpha in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [GENE]@GENE$[/GENE] (TNF)-alpha in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [200, 206], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_idx_in_text_with_typed_entity_marker": [206, 212], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [246, 255], "entity_2_idx_in_text_with_entity_marker": [259, 268], "entity_2_idx_in_text_with_typed_entity_marker": [268, 277], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_296", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [E1]@GENE$[/E1] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [GENE]@GENE$[/GENE] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [143, 149], "entity_1_idx_in_text_with_entity_marker": [147, 153], "entity_1_idx_in_text_with_typed_entity_marker": [149, 155], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [228, 237], "entity_2_idx_in_text_with_entity_marker": [241, 250], "entity_2_idx_in_text_with_typed_entity_marker": [250, 259], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_179", "text": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (@GENE$, nucleotide oligomerization domain 2) are associated with @DISEASE$ (CD).", "text_with_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein ([E1]@GENE$[/E1], nucleotide oligomerization domain 2) are associated with [E2]@DISEASE$[/E2] (CD).", "text_with_typed_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein ([GENE]@GENE$[/GENE], nucleotide oligomerization domain 2) are associated with [DISEASE]@DISEASE$[/DISEASE] (CD).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [151, 157], "entity_1_idx_in_text_with_entity_marker": [155, 161], "entity_1_idx_in_text_with_typed_entity_marker": [157, 163], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [216, 225], "entity_2_idx_in_text_with_entity_marker": [229, 238], "entity_2_idx_in_text_with_typed_entity_marker": [238, 247], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_63", "text": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the @GENE$ gene revealed one SNP and one haplotype associated with the phenotype of @DISEASE$ in the CVCR sample.", "text_with_entity_marker": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the [E1]@GENE$[/E1] gene revealed one SNP and one haplotype associated with the phenotype of [E2]@DISEASE$[/E2] in the CVCR sample.", "text_with_typed_entity_marker": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the [GENE]@GENE$[/GENE] gene revealed one SNP and one haplotype associated with the phenotype of [DISEASE]@DISEASE$[/DISEASE] in the CVCR sample.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [81, 87], "entity_1_idx_in_text_with_entity_marker": [85, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 93], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [161, 170], "entity_2_idx_in_text_with_entity_marker": [174, 183], "entity_2_idx_in_text_with_typed_entity_marker": [183, 192], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_94", "text": "Individual LOXL1 SNPs, @GENE$, rs3825942, and rs2165241, were not associated with @DISEASE$ in the Chinese population.", "text_with_entity_marker": "Individual LOXL1 SNPs, [E1]@GENE$[/E1], rs3825942, and rs2165241, were not associated with [E2]@DISEASE$[/E2] in the Chinese population.", "text_with_typed_entity_marker": "Individual LOXL1 SNPs, [GENE]@GENE$[/GENE], rs3825942, and rs2165241, were not associated with [DISEASE]@DISEASE$[/DISEASE] in the Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_267", "text": "We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [E1]@GENE$[/E1] and type 2 diabetes, overweight, [E2]@DISEASE$[/E2] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and type 2 diabetes, overweight, [DISEASE]@DISEASE$[/DISEASE] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [75, 81], "entity_1_idx_in_text_with_entity_marker": [79, 85], "entity_1_idx_in_text_with_typed_entity_marker": [81, 87], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [115, 124], "entity_2_idx_in_text_with_entity_marker": [128, 137], "entity_2_idx_in_text_with_typed_entity_marker": [137, 146], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_234", "text": "The @GENE$ and the T-allele of NOS1AP rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The [E1]@GENE$[/E1] and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_55", "text": "The @GENE$, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of @DISEASE$ induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "text_with_entity_marker": "The [E1]@GENE$[/E1], which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of [E2]@DISEASE$[/E2] induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE], which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of [DISEASE]@DISEASE$[/DISEASE] induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_155", "text": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) @GENE$ (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.", "text_with_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) [E1]@GENE$[/E1] (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [E2]@DISEASE$[/E2] and can serve as biomarkers for screening for this virulent disease.", "text_with_typed_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) [GENE]@GENE$[/GENE] (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [DISEASE]@DISEASE$[/DISEASE] and can serve as biomarkers for screening for this virulent disease.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [154, 160], "entity_1_idx_in_text_with_entity_marker": [158, 164], "entity_1_idx_in_text_with_typed_entity_marker": [160, 166], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [655, 664], "entity_2_idx_in_text_with_entity_marker": [668, 677], "entity_2_idx_in_text_with_typed_entity_marker": [677, 686], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_274", "text": "In this study, the @GENE$ polymorphism observed in the MDR1 gene was not found to be a risk factor for @DISEASE$ or ulcerative colitis.", "text_with_entity_marker": "In this study, the [E1]@GENE$[/E1] polymorphism observed in the MDR1 gene was not found to be a risk factor for [E2]@DISEASE$[/E2] or ulcerative colitis.", "text_with_typed_entity_marker": "In this study, the [GENE]@GENE$[/GENE] polymorphism observed in the MDR1 gene was not found to be a risk factor for [DISEASE]@DISEASE$[/DISEASE] or ulcerative colitis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_121", "text": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, @GENE$) are associated with @DISEASE$ (CD).", "text_with_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, [E1]@GENE$[/E1]) are associated with [E2]@DISEASE$[/E2] (CD).", "text_with_typed_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, [GENE]@GENE$[/GENE]) are associated with [DISEASE]@DISEASE$[/DISEASE] (CD).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [157, 163], "entity_1_idx_in_text_with_entity_marker": [161, 167], "entity_1_idx_in_text_with_typed_entity_marker": [163, 169], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_236", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and manic disorders, including @DISEASE$ and bipolar disorder.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both psychotic and manic disorders, including [E2]@DISEASE$[/E2] and bipolar disorder.", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both psychotic and manic disorders, including [DISEASE]@DISEASE$[/DISEASE] and bipolar disorder.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [142, 151], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_idx_in_text_with_typed_entity_marker": [164, 173], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_84", "text": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), @GENE$ (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.", "text_with_entity_marker": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), [E1]@GENE$[/E1] (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), [GENE]@GENE$[/GENE] (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [138, 144], "entity_1_idx_in_text_with_entity_marker": [142, 148], "entity_1_idx_in_text_with_typed_entity_marker": [144, 150], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [390, 399], "entity_2_idx_in_text_with_entity_marker": [403, 412], "entity_2_idx_in_text_with_typed_entity_marker": [412, 421], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_247", "text": "Genetic variation in the promoter region of @GENE$ is associated with @DISEASE$.", "text_with_entity_marker": "Genetic variation in the promoter region of [E1]@GENE$[/E1] is associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Genetic variation in the promoter region of [GENE]@GENE$[/GENE] is associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [44, 50], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_idx_in_text_with_typed_entity_marker": [50, 56], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_183", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (@DISEASE$) or bloody diarrhea than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome ([E2]@DISEASE$[/E2]) or bloody diarrhea than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome ([DISEASE]@DISEASE$[/DISEASE]) or bloody diarrhea than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [120, 129], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_idx_in_text_with_typed_entity_marker": [142, 151], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_167", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in GPx1 and @GENE$ double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [E1]@DISEASE$[/E1] in GPx1 and [E2]@GENE$[/E2] double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [DISEASE]@DISEASE$[/DISEASE] in GPx1 and [GENE]@GENE$[/GENE] double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [106, 115], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_idx_in_text_with_typed_entity_marker": [115, 124], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [128, 134], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_idx_in_text_with_typed_entity_marker": [153, 159], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_131", "text": "Our work supported @GENE$ genetic variants as possible susceptibility factors for @DISEASE$ and fractures in humans.", "text_with_entity_marker": "Our work supported [E1]@GENE$[/E1] genetic variants as possible susceptibility factors for [E2]@DISEASE$[/E2] and fractures in humans.", "text_with_typed_entity_marker": "Our work supported [GENE]@GENE$[/GENE] genetic variants as possible susceptibility factors for [DISEASE]@DISEASE$[/DISEASE] and fractures in humans.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_33", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes @GENE$ ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes [E2]@GENE$[/E2] ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes [GENE]@GENE$[/GENE] ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [398, 404], "entity_2_idx_in_text_with_entity_marker": [411, 417], "entity_2_idx_in_text_with_typed_entity_marker": [423, 429], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_235", "text": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to @DISEASE$ (CD) risk in general and of the @GENE$ variant in particular.", "text_with_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to [E1]@DISEASE$[/E1] (CD) risk in general and of the [E2]@GENE$[/E2] variant in particular.", "text_with_typed_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to [DISEASE]@DISEASE$[/DISEASE] (CD) risk in general and of the [GENE]@GENE$[/GENE] variant in particular.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [102, 111], "entity_1_idx_in_text_with_entity_marker": [106, 115], "entity_1_idx_in_text_with_typed_entity_marker": [111, 120], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [144, 150], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_idx_in_text_with_typed_entity_marker": [169, 175], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_103", "text": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for @GENE$ (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.", "text_with_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for [E1]@GENE$[/E1] (uncorrected p = .004) to the affected [E2]@DISEASE$[/E2] offspring were observed.", "text_with_typed_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for [GENE]@GENE$[/GENE] (uncorrected p = .004) to the affected [DISEASE]@DISEASE$[/DISEASE] offspring were observed.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [200, 206], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_idx_in_text_with_typed_entity_marker": [206, 212], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [246, 255], "entity_2_idx_in_text_with_entity_marker": [259, 268], "entity_2_idx_in_text_with_typed_entity_marker": [268, 277], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_263", "text": "These results strongly suggest that the @GENE$ polymorphism in the CHI3L1 promoter region is associated with the risk of @DISEASE$.", "text_with_entity_marker": "These results strongly suggest that the [E1]@GENE$[/E1] polymorphism in the CHI3L1 promoter region is associated with the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results strongly suggest that the [GENE]@GENE$[/GENE] polymorphism in the CHI3L1 promoter region is associated with the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [40, 46], "entity_1_idx_in_text_with_entity_marker": [44, 50], "entity_1_idx_in_text_with_typed_entity_marker": [46, 52], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [121, 130], "entity_2_idx_in_text_with_entity_marker": [134, 143], "entity_2_idx_in_text_with_typed_entity_marker": [143, 152], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_248", "text": "Expression of VEGFR-1 (@GENE$) in @DISEASE$ is associated with VEGF expression and with node-negative tumour stage.", "text_with_entity_marker": "Expression of VEGFR-1 ([E1]@GENE$[/E1]) in [E2]@DISEASE$[/E2] is associated with VEGF expression and with node-negative tumour stage.", "text_with_typed_entity_marker": "Expression of VEGFR-1 ([GENE]@GENE$[/GENE]) in [DISEASE]@DISEASE$[/DISEASE] is associated with VEGF expression and with node-negative tumour stage.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [34, 43], "entity_2_idx_in_text_with_entity_marker": [47, 56], "entity_2_idx_in_text_with_typed_entity_marker": [56, 65], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_309", "text": "In a family, we observed @GENE$ associated with @DISEASE$.", "text_with_entity_marker": "In a family, we observed [E1]@GENE$[/E1] associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In a family, we observed [GENE]@GENE$[/GENE] associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [25, 31], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_idx_in_text_with_typed_entity_marker": [31, 37], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_62", "text": "Our results suggested that common genetic variants in @GENE$ may modulate the risk of developing @DISEASE$ in the study population, particularly in non-smokers.", "text_with_entity_marker": "Our results suggested that common genetic variants in [E1]@GENE$[/E1] may modulate the risk of developing [E2]@DISEASE$[/E2] in the study population, particularly in non-smokers.", "text_with_typed_entity_marker": "Our results suggested that common genetic variants in [GENE]@GENE$[/GENE] may modulate the risk of developing [DISEASE]@DISEASE$[/DISEASE] in the study population, particularly in non-smokers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [54, 60], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 66], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
